Join Our Team

Careers

Join Our Team

The successful clinical translation of new technologies to the clinic requires a wide range of expertise. Our multi-disciplinary group of more than 100 prostate cancer scientists, physicians, trainees and healthcare employees from five leading Alberta health research institutions are working with an international collaborative network to achieve our translational research goals – to make a meaningful impact on health policy and the outcomes of patients living with prostate cancer.

Our overall goal is to improve patient outcomes and quality of life by developing and successfully translating to the clinic innovative tests that are more sensitive, more accurate and more cost-effective than current tests for prostate cancer.

Submit Your Resume

  • Accepted file types: pdf, doc, rtf.
    .pdf, .doc, .rtf

Congratulations to APCaRI recipients of JAHIP grants!

Congratulations to Drs. John Lewis, Eric Hyndman, Morley Hollenberg and Harvey Quon for being awarded each with a JAHIP grant (Johnson & Johnson Alberta Health Innovation Partnership) to better diagnose prostate cancer using different platforms and to determine mutations in patients with high-risk PCa.

This is a great opportunity to start long-lasting partnerships with J&J and the University Hospital Foundation and to develop new and better tests for PCa.

The original plan was to fund 2 applications, however, due to the high quality of the proposals, the committee decided to grant 2 more.

- Catalina Vasquez